Statistics
Publications
17
Citations
483
H-Index
14
Active since
2012
Xiangyu Jin is an author at Zhejiang Cancer Hospital specializing in oncology, life sciences, and medicine.
Publications per year
2012–2025
17
17
Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7
Xiangyu Jin, Didi Liu, Xinru Zhou et al. · Cell Reports Medicine · 2023 · 48 citations · Full text
Human Serum Albumin Nanoparticles as a Novel Delivery System for Cabazitaxel.
Guoming Zhou, Xiangyu Jin, Ping Zhu et al. · PubMed · 2016 · 36 citations
1–5 of 17